| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 04/06/2005 | CN1604965A 生长激素融合蛋白 Growth hormone fusion protein |
| 04/06/2005 | CN1604901A Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/06/2005 | CN1604900A 6-aminomorphinane derivatives, method for production and use thereof |
| 04/06/2005 | CN1604772A Transdermal transport of compounds |
| 04/06/2005 | CN1602881A Diabetin for injection and its preparation process |
| 04/06/2005 | CN1602874A Sustained release preparation of propylthiouracil and its preparation method |
| 04/06/2005 | CN1195776C Treatmet of obesity |
| 04/06/2005 | CN1195772C Nb heterocyclic 8-modified adenosine derivs. |
| 04/06/2005 | CN1195743C Dihydro-1, 3, 5-triazine amine derivatives and their therapeutic uses |
| 04/06/2005 | CN1195513C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses |
| 04/06/2005 | CN1195501C Transdermal therapeutic system (TTS) for administrating sexual steroid hormones |
| 04/05/2005 | US6875793 Once-a-day controlled release sulfonylurea formulation |
| 04/05/2005 | US6875789 Pyrazole-derived kinase inhibitors and uses thereof |
| 04/05/2005 | US6875779 Cyclooxygenase inhibitor |
| 04/05/2005 | US6875775 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 04/05/2005 | US6875736 Methods for identifying RNA binding compounds |
| 03/31/2005 | WO2005028515A1 Recombinant antibody against human insulin-like growth factor |
| 03/31/2005 | WO2005028452A1 Substituted triazole derivatives as oxytocin antagonists |
| 03/31/2005 | WO2005028438A1 Novel piperidine derivative |
| 03/31/2005 | WO2005027960A1 Liquid human growth hormone formulation containing polyethylene glycol |
| 03/31/2005 | WO2005027928A1 2-alkylidene-19-nor-vit amin d derivatives for the treatment of hypocalcemic tetany or hyproparathyroidism |
| 03/31/2005 | WO2005027922A1 2-alkylidene-19-nor-vitamin d derivatives for the treatment of hypogonadism or andropause |
| 03/31/2005 | WO2005027912A1 Steroidal quinols and their use for estrogen replacement therapy |
| 03/31/2005 | WO2005027892A1 Early insulin secretion promoter |
| 03/31/2005 | WO2005027891A1 Accelerator for initial insulin secretion |
| 03/31/2005 | WO2005002600A3 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus |
| 03/31/2005 | WO2003040329A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/31/2005 | US20050070720 11-Beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 03/31/2005 | US20050070689 Nucleotide sequences coding transmembrane activator and CAML interactor (TACI) protein for use in treatment and prevention of autoimmune disorders |
| 03/31/2005 | US20050070594 Use of angiotensin II receptor antagonists |
| 03/31/2005 | US20050070590 possessing anti-cancer activity, anti-inflammatory activity, anti-obesity activity, and/or hair growth promotion activity |
| 03/31/2005 | US20050070582 For example,1-{[2-(3,5-dimethylphenoxy)-5-nitrophenyl]sulfonyl}-4-ethylpiperazine or 1-{[2-(3,5-dichlorophenoxy)-5-nitrophenyl]sulfonyl}piperazine; for the treatment of asthma, atopic dermatitis, allergic rhinitis and other inflammatory/immunological disorders |
| 03/31/2005 | US20050070557 Use of pyrazolo(4,3-d)pyrimidine derivatives; for example, 5-(3-chloro-benzyl)-3-isopropyl-1,6-dihydro-pyrazolo[4,3-d]pyrimidin-7-one |
| 03/31/2005 | US20050070517 Oxazol/thiazol-derivatives activators of the hppar-alpha receptor |
| 03/31/2005 | US20050070488 Estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy |
| 03/31/2005 | US20050070459 treating Type I diabetes, septic shock, multiple sclerosis, inflammatory bowel disease (IBD) and Crohn's disease with BoroProline-Pinacol or other proline derivatives; dipeptidylpeptidase inhibitor |
| 03/31/2005 | US20050069876 Polypeptide for use in diagnosis, treatment and prevention of cell proliferative, autoimmune, inflammatory, cardiovascular, neurological and developmental disorders. |
| 03/31/2005 | US20050069547 Binding protein; therapy for bone tumors |
| 03/31/2005 | CA2551037A1 Novel piperidine derivative |
| 03/31/2005 | CA2540172A1 Liquid human growth hormone formulation containing polyethylene glycol |
| 03/31/2005 | CA2540138A1 Recombinant antibody against human insulin-like growth factor |
| 03/31/2005 | CA2539661A1 Steroidal quinols and their use for estrogen replacement therapy |
| 03/30/2005 | EP1517914A2 9-alpha-substituted estratrienes as selectively active estrogen |
| 03/30/2005 | EP1517905A1 Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases |
| 03/30/2005 | EP1517897A2 Benzimidazole compounds and their use as estrogen agonists/antagonists |
| 03/30/2005 | EP1517892A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof |
| 03/30/2005 | EP1517891A1 Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof |
| 03/30/2005 | EP1517883A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 03/30/2005 | EP1517667A2 Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects |
| 03/30/2005 | EP1322350B1 E-ptfe foil impregnated with an encapsulated bioactive substance |
| 03/30/2005 | EP1246692B1 Templating of uncharged solid particles by polymer multilayers |
| 03/30/2005 | EP1237898B1 N?6 heterocyclic 8-modified adenosine derivatives |
| 03/30/2005 | EP0980369B1 Sulfonamides for treatment of endothelin-mediated disorders |
| 03/30/2005 | CN1602317A Angiopoietin-2 specific binding agents |
| 03/30/2005 | CN1602307A Substituted 6h-dibenzo[c, h]chromenes as estrogenic agents |
| 03/30/2005 | CN1602299A Crystals of bicalutamide and process for their production |
| 03/30/2005 | CN1602298A Synthesis of oxygen-substituted benzocycloheptenes, used as valuable intermediate products for producing tissue-selective oestrogens |
| 03/30/2005 | CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 03/30/2005 | CN1602189A Composition comprising cysteamine for improving lactation in dairy animals |
| 03/30/2005 | CN1602187A Valdecoxib-based composition prepared by spray drying process and exhibiting rapid oral dissolution |
| 03/30/2005 | CN1194733C Medicine for treating hyperthyroidism and its prepn |
| 03/30/2005 | CN1194701C Application of icaritin or demethylicaritin in preparing estrogen receptor moderator |
| 03/29/2005 | US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents |
| 03/29/2005 | US6872728 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 03/29/2005 | US6872712 Cyclic glycerophosphates and analogs thereof |
| 03/29/2005 | US6872700 Methods for glucagon suppression |
| 03/29/2005 | CA2335186C Pyrrolo[2,3-d]pyrimidine compounds |
| 03/29/2005 | CA2195745C Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens |
| 03/29/2005 | CA2100514C 17-spiromethylene steroids |
| 03/24/2005 | WO2005026335A2 Insulin-producing bone marrow derived cells and methods of generating and using same |
| 03/24/2005 | WO2005025579A1 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
| 03/24/2005 | WO2005025570A1 Use of antagonists of hepatic sympathetic nerve activity |
| 03/24/2005 | WO2005005477A3 Stabilised insulin compositions |
| 03/24/2005 | WO2005000775A3 Cyclohexyl derivatives as selective estrogen receptor modulators |
| 03/24/2005 | WO2004017948A8 Use of lck inhibitor for treatment of immunologic diseases |
| 03/24/2005 | WO2004000204A3 Labelled somatostatin analogs backbone cyclized through metal complexation |
| 03/24/2005 | WO2003104407A3 T cell receptor cdr3 sequences and methods for detection |
| 03/24/2005 | WO2002092759A9 Molecules for disease detection and treatment |
| 03/24/2005 | US20050065140 Antidepressant; side effect reduction |
| 03/24/2005 | US20050065128 Glandular disorders |
| 03/24/2005 | US20050065113 Starch derivatives, starch active substance conjugates, method for the production thereof and their use as medicaments |
| 03/24/2005 | US20050065086 Adjust drug releasing characteristics, bioavailability of oral drug |
| 03/24/2005 | US20050065080 Use of leptin in fertility |
| 03/24/2005 | US20050064409 Chp for use as marker for sepsis-type inflammatory diseases |
| 03/24/2005 | US20050063943 Conjugated of hydroxyalkyl starch and an active agent |
| 03/24/2005 | US20050063905 Administering a RADIONUCLIDE COMPLEXED WITH A CHELATING AGENT SUCH AS MACROCYCLIC AMINOPHOSPHONIC ACID, or tetraazacyclododecanetetramethylenephosphonic acid (DOTMP); polycythemia vera, macroglobulinemia (Waldenstrom syndrome), megakaryocytic myelosis, malignant histiocytosis |
| 03/24/2005 | CA2538415A1 Use of antagonists of hepatic sympathetic nerve activity |
| 03/24/2005 | CA2537663A1 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
| 03/23/2005 | EP1516597A1 Drug eluting stent |
| 03/23/2005 | EP1515959A1 Pharmaceutical salts of reboxetine |
| 03/23/2005 | EP1515947A1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament |
| 03/23/2005 | EP1515725A2 Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions |
| 03/23/2005 | EP1515708A1 Combinations of pde-v inhibitors and nk1 antagonists for the treatment of depression |
| 03/23/2005 | EP1105120B1 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION |
| 03/23/2005 | CN1599737A Ring fused pyrazole derivatives |
| 03/23/2005 | CN1599730A Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof |
| 03/23/2005 | CN1599612A Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes |
| 03/23/2005 | CN1599607A Carbinols for the treatment of neuropathic dysfunction |
| 03/23/2005 | CN1599606A Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins |
| 03/23/2005 | CN1597677A Compounds and methods for modulation of estrogen receptors |